4.450CAD-3.05%Mkt Cap: 139.17M CADP/E: —Last update: 2026-06-01
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and inter…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap139.17M CAD
Enterprise Value175.15M CAD
Revenue (TTM)55.74M CAD
Gross Profit45.42M CAD
Net Income (TTM)-12.43M CAD
Revenue/Share1.775 CAD
Last Price4.450 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees85
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-110.51
PEG—
EV/EBITDA10.10
EV/Revenue3.14
P/S2.58
P/B1.87
EPS (TTM)-0.44
EPS (Forward)-0.04
52W Range
0.001077% of range5.765
52W High5.765 CAD
52W Low0.0010 CAD
Profitability
Gross Margin81.83%
Oper. Margin-17.22%
EBITDA Margin31.12%
Profit Margin-22.40%
ROE-20.16%
ROA-9.04%
Growth
Revenue Growth1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF17.13M CAD
CapEx (TTM)1.70M CAD
FCF Margin37.22%
FCF Yield14.91%
Net Debt31.60M CAD
Net Debt/EBITDA1.82
Balance Sheet
Debt/Equity0.81
Current Ratio1.00
Quick Ratio0.71
Book Value/Sh2.454 CAD
Cash/Share0.3940 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield1.73%
Payout Ratio0.00%
Ex-Div DateApr 27, 2023
Pay DateJun 15, 2023
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)7.143 CAD
Target Range4.506 CAD – 12.04 CAD
# Analysts4
Ownership
Shares Out.31.27M
Float19.62M
Insiders0.53%
Institutions43.42%
Short Interest
Short Ratio1.0d
Short % Out.0.02%
Shares Short7.05K
Short (prev mo.)14.53K
Technical
SMA 504.554 (-2.3%)
SMA 2004.905 (-9.3%)
Beta0.83
S&P 52W Chg27.70%
Avg Vol (30d)5.71K
Avg Vol (10d)4.72K
Technical Indicators
RSI (14)48.1
MACD-0.0003
MACD Signal0.0145
MACD Hist.-0.0149
BB Upper4.752 CAD
BB Middle4.641 CAD
BB Lower4.529 CAD
BB Width4.82%
ATR (14)0.1254 CAD
Vol Ratio (20d)0.43x